Analyst Ratings for Y-mAbs Therapeutics (YMAB)

YMAB Rating Summary

YMAB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on YMAB
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $58.83 (+79.8%) * Over Last 12-Mos
Rating Score: 9.1 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/7/2021 BofA Securities Alec Stranahan Upgrade Buy
(Neutral)
56.00
(N/A)
28.65
(32.72)
14.21% Details
4/23/2021 Cowen Joe Thome New Coverage Outperform
(N/A)
N/A
(N/A)
27.04
(32.72)
21.01% Details
Like YMAB Ratings? Also take a look at TAK, IOVA, EOLS, LIZI

YMAB Ratings News